Search results
Results From The WOW.Com Content Network
Otitis media is a group of inflammatory diseases of the middle ear. [2] One of the two main types is acute otitis media (AOM), [3] an infection of rapid onset that usually presents with ear pain. [1] In young children this may result in pulling at the ear, increased crying, and poor sleep. [1] Decreased eating and a fever may also be present. [1]
Autoinflation is a minimally invasive procedure to treat serous non-infectious otitis media, in which a nasal balloon is inserted into the nasopharynx, followed by the application of pressure to the sinus cavities by forcibly contracting the diaphragm against the closed nasal passageways.
The most common aetiology of acute otitis externa is bacterial infection, [5] while chronic cases are often associated with underlying skin diseases such as eczema or psoriasis. [6] A third form, malignant otitis externa, or necrotising otitis externa, is a potentially life-threatening, invasive infection of the external auditory canal and ...
Otitis media. Acute otitis media is an infection of the middle ear. More than 80% of children experience at least one episode of otitis media by age 3 years. [23] Acute otitis media is also most common in these first 3 years of life, though older children may also experience it. [19]
"Quantitative PCR of ear discharge from Indigenous Australian children with acute otitis media with perforation supports a role for Alloiococcus otitidis as a secondary pathogen". BMC Ear, Nose and Throat Disorders. 12 (1): 11. doi: 10.1186/1472-6815-12-11. PMC 3546424. PMID 23033913
Antipyrine and benzocaine ear drops is a medication for the treatment of ear pain caused by otitis media. It combines antipyrine , an NSAID , and benzocaine , a local anaesthetic in order to treat ear pain, alongside hydroxyquinoline sulfate, an antiseptic and preservative.
Alloiococcus otitis is a species of bacteria first isolated from human middle-ear fluid, the type species of its monotypic genus. The type strain is NCFB 2890. The type strain is NCFB 2890. [ 1 ]
In a post-marketing surveillance evaluating safety in 2006 children with acute otitis media treated with cefditoren (median daily dose: 10.0 mg/kg with a median total treatment period of 7 days), the incidence of adverse reactions was 1.79%, without unexpected or serious adverse drug reactions reported.